Hybrid minimally invasive esophagectomy reduces morbidity in esophageal cancer
from HemOnc Today
Hybrid minimally invasive esophagectomy reduced incidence of major morbidity compared with open esophagectomy for patients with esophageal cancer, according to long-term results from a randomized, controlled phase 3 trial presented at the European Society for Medical Oncology Congress.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063